David M. Goldstein

Technik-/Wissenschafts-/F&E-Leiter bei PRINCIPIA BIOPHARMA INC.

58 Jahre

Health Technology

Consumer Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Severin Schwan	M	57	ROCHE HOLDING AG	16 Jahre
Chris Varma	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 Jahre
André S. Hoffmann	M	66	ROCHE HOLDING AG	28 Jahre
Othman Laraki	M	46	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Betsy Santos	F	-	PRINCIPIA BIOPHARMA INC.	-
Daniel K. Nomura	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 Jahre
Roberto Zoncu	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 Jahre
Thomas Schinecker	M	49	ROCHE HOLDING AG	21 Jahre
Luke Evnin	M	60	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
John Reed	M	65	PRINCIPIA BIOPHARMA INC.	-
Paul Laland	M	-	PRINCIPIA BIOPHARMA INC.	-
Pamela Klein	M	63	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	1 Jahre
Janwillem Naesens	M	41	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Cameron Wheeler	M	45	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Setareh Pouraghabagher	F	53	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	2 Jahre
Joan S Brugge	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
DeAnne Shirley Julius	M	75	ROCHE HOLDING AG	14 Jahre
Erich Hunziker	M	70	ROCHE HOLDING AG	10 Jahre
Andreas Oeri	M	75	ROCHE HOLDING AG	24 Jahre
Walter Frey	M	80	ROCHE HOLDING AG	10 Jahre
John Bell	M	71	ROCHE HOLDING AG	19 Jahre
Lodewijk J. R. de Vink	M	78	ROCHE HOLDING AG	9 Jahre
Christopher Chai	M	58	PRINCIPIA BIOPHARMA INC.	7 Jahre
Martin Babler	M	59	PRINCIPIA BIOPHARMA INC.	9 Jahre
Peter Thompson	M	64	PRINCIPIA BIOPHARMA INC.	8 Jahre
Paul Bulcke	M	69	ROCHE HOLDING AG	11 Jahre
Horst Teltschik	M	83	ROCHE HOLDING AG	-
Simeon George	M	46	PRINCIPIA BIOPHARMA INC.	9 Jahre
Wolfgang Ruttenstorfer	M	73	ROCHE HOLDING AG	4 Jahre
Christoph Franz	M	64	ROCHE HOLDING AG	12 Jahre
Roy C. Hardiman	M	64	PRINCIPIA BIOPHARMA INC.	5 Jahre
Pius Baschera	M	73	ROCHE HOLDING AG	10 Jahre
Bruno Gehrig	M	77	ROCHE HOLDING AG	9 Jahre
Domenico Scala	M	59	ROCHE HOLDING AG	8 Jahre
John Smither	M	71	PRINCIPIA BIOPHARMA INC.	-
Henri-Paul Meier	M	-	ROCHE HOLDING AG	-
Dan Becker	M	49	PRINCIPIA BIOPHARMA INC.	3 Jahre
Clive Meanwell	M	67	ROCHE HOLDING AG	9 Jahre
Arthur Levinson	M	73	ROCHE HOLDING AG	-
Alan Colowick	M	61	PRINCIPIA BIOPHARMA INC.	3 Jahre
William Burns	M	76	ROCHE HOLDING AG	4 Jahre
Beatrice Weder di Mauro	M	57	ROCHE HOLDING AG	10 Jahre
Vincent Charlon	M	-	ROCHE HOLDING AG	8 Jahre
Steve Krognes	M	56	ROCHE HOLDING AG	5 Jahre
Jean-Jacques Garaud	M	68	ROCHE HOLDING AG	5 Jahre
Klaus Gustav Strein	M	-	ROCHE HOLDING AG	13 Jahre
Unni Hjelmaas	F	-	ROCHE HOLDING AG	3 Jahre
Michael Burgess	M	61	ROCHE HOLDING AG	-
David Kabakoff	M	76	PRINCIPIA BIOPHARMA INC.	2 Jahre
Torsten Hoffmann	M	57	ROCHE HOLDING AG	16 Jahre
Greg S. Yap	M	-	ROCHE HOLDING AG	3 Jahre
Shawn Tomasello	F	65	PRINCIPIA BIOPHARMA INC.	1 Jahre
Michael Mulqueen	M	-	ROCHE HOLDING AG	13 Jahre
Michael Byrnes	M	47	PRINCIPIA BIOPHARMA INC.	-
Olivia Ware	F	67	PRINCIPIA BIOPHARMA INC.	2 Jahre
Luca Santarelli	M	55	ROCHE HOLDING AG	8 Jahre
Shao Lee Lin	M	57	PRINCIPIA BIOPHARMA INC.	1 Jahre
Christopher Vann	M	59	ROCHE HOLDING AG	22 Jahre
Stefani Wolff	F	62	PRINCIPIA BIOPHARMA INC.	4 Jahre
Dolca Thomas	M	53	PRINCIPIA BIOPHARMA INC.	2 Jahre
Marc M. Gibeley	M	59	ROCHE HOLDING AG	5 Jahre
Anton Affentranger	M	68	ROCHE HOLDING AG	-
Dirk W. Kirsten	M	56	ROCHE HOLDING AG	2 Jahre
Bradley Bolzon	M	64	ROCHE HOLDING AG	4 Jahre
Peter Brabeck-Letmathe	M	79	ROCHE HOLDING AG	10 Jahre
Clarence Machado	M	60	PRINCIPIA BIOPHARMA INC.	1 Jahre
Lewis J. Shuster	M	68	PRINCIPIA BIOPHARMA INC.	-
Stephen Hill	M	65	ROCHE HOLDING AG	2 Jahre
Hany Massarany	M	62	ROCHE HOLDING AG	2 Jahre
Franz Humer	M	76	ROCHE HOLDING AG	19 Jahre
Richard Scheller	M	70	ROCHE HOLDING AG	5 Jahre
Rolf Hänggi	M	81	ROCHE HOLDING AG	10 Jahre
Per-Olof Attinger	M	64	ROCHE HOLDING AG	-
Eduard Enrico Holdener	M	79	ROCHE HOLDING AG	12 Jahre
Rolf Schläpfer	M	68	ROCHE HOLDING AG	-
Gerald Heinz Möller	M	80	ROCHE HOLDING AG	-
Phyllis Whiteley	M	-	ROCHE HOLDING AG	5 Jahre
Jürg Witmer	M	75	ROCHE HOLDING AG	21 Jahre
Myriam Meyer Stutz	M	62	ROCHE HOLDING AG	3 Jahre
Steven G. Gourlay	M	64	PRINCIPIA BIOPHARMA INC.	5 Jahre
Michael Dybbs	M	49	PRINCIPIA BIOPHARMA INC.	2 Jahre
Mohammad Masjedizadeh	M	-	PRINCIPIA BIOPHARMA INC.	5 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Schweiz	49	59,76%
Vereinigte Staaten	33	40,24%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen

Börse
Insiders
David M. Goldstein
Persönliches Netzwerk